+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
AKSHARCHEM

AksharChem (India) Share Price

 

 

AksharChem (India) live price: ₹206.8. It opened at ₹207 vs previous close ₹202; intraday high/low: ₹209/₹205. The 50 & 200 DMA stand at ₹203.09/₹223.49.

AksharChem (India) Performance

  • Today's Low
  • ₹205
  • Today's High
  • ₹209
  • 52 Week Low
  • ₹141
  • 52 Week High
  • ₹331
  • Open Price₹207
  • Previous Close₹202
  • Volume1,639
  • 50 DMA₹203.09
  • 100 DMA₹208.43
  • 200 DMA₹223.49

AksharChem (India) Chart

Investment Returns

  • Over 1 Month -1.39%
  • Over 3 Month + 21%
  • Over 6 Month -15.42%
  • Over 1 Year -20.54%

Smart Investing Starts Here Start SIP with AksharChem (India) for Steady Growth!

Invest Now

AksharChem (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -378.8
  • PEG Ratio
  • 3.5
  • Market Cap Cr
  • 166
  • P/B Ratio
  • 0.6
  • Average True Range
  • 12.55
  • EPS
  • 0
  • Dividend Yield
  • 0.4
  • MACD Signal
  • 3.75
  • RSI
  • 48.16
  • MFI
  • 78.5

Latest Stock News Updates

Aksharchem, which delivered triple digit returns over the last year, is one of Dolly Khanna's recent portfolio bets

The focus of superstar shareholders in the media tends to be big names like Rakesh Jhunjhunwala, but there are other large shareholders with interesting, diverse portfolios and large holdings. Here we compare Rakesh Jhunjhunwala and Dolly Khanna's portfolios. Dolly Khanna's portfolio, as of the latest numbers, have four of 25 stocks in the portfolio that are sharp underperformers, but over ten stocks have provided over triple-digit returns in share price over the past year (although three of these - Aksharchem, Rain Industries and Shreyans - are recent investments) Rakesh Jhunjhunwala's portfolio has seen 10 out of 25 stocks have underperformed, with either single digit or negative returns. In the portfolio, five of 32 stocks that have seen over triple digit returns in the last year. What is also interesting is how different the focus of these two portfolios are. Dolly Khanna's portfolio has multiple investments in sectors like sugar, which Jhunjhunwala doesn't have an investment in. Sugar companies saw a big boost in terms of regulation over the last year, with the government limiting imports to protect prices for Indian players. Dolly Khanna also invested in plastic, yarn, chemicals and other old school industries. Jhunjhunwala on the other hand prefers companies in his portfolio that are in pharma, finance - HFCs and Banks - tech and the retail sector, companies that rely more on the health of export markets, the urban ecosystem and growth of India's middle class consumer base. It will be interesting to see how these portfolios change over the coming months as these investors look at new macroeco numbers and make fresh bets.

Aksharchem revenues up 44.5% in Q3FY17

AksharChem has announced a revenue growth of 44.5% to Rs. 71.7 crore for its December'16 quarter, compared to the same period the previous year. The company's net profits are up three times to Rs. 17.6 crore this Q3, compared to Rs. 5.06 crore in last year's third quarter. The stock is sharply up today on the news of its results.

AksharChem (India) Financials

AksharChem (India) Technicals

EMA & SMA

Current Price
₹206.80
+ 4.54 (2.24%)
pointer
  • Bearish Moving Average 10
  • Bullish Moving Average 6
  • 20 Day
  • ₹207.20
  • 50 Day
  • ₹203.10
  • 100 Day
  • ₹208.40
  • 200 Day
  • ₹223.50

Resistance and Support

204.08 Pivot Speed
  • R3 218.12
  • R2 214.05
  • R1 208.15
  • S1 198.18
  • S2 194.11
  • S3 188.21

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Aksharchem India has an operating revenue of Rs. 372.43 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of -1% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 7%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 7% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 34 which is a POOR score indicating inconsistency in earnings, a RS Rating of 50 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 43 indicates it belongs to a fair industry group of Chemicals-Specialty and a Master Score of B is close to being the best. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

AksharChem (India) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-21 Audited Results
2026-01-28 Quarterly Results
2025-11-12 Quarterly Results
2025-07-25 Quarterly Results & Others To consider other business matters. per share(35%)Final Dividend
2025-05-21 Audited Results & Final Dividend
Date Purpose Remarks
2025-09-05 FINAL Rs.0.75 per share(7.5%)Final Dividend
View AksharChem (India) Dividend History Arrow

AksharChem (India) Shareholding Pattern

62.7%
0.06%
0%
27.44%
9.8%

AksharChem (India) FAQs

AksharChem (India) share price is ₹206 As on 12 June, 2026 | 13:20

The Market Cap of AksharChem (India) is ₹166.1 Cr As on 12 June, 2026 | 13:20

The P/E ratio of AksharChem (India) is -378.8 As on 12 June, 2026 | 13:20

The PB ratio of AksharChem (India) is 0.6 As on 12 June, 2026 | 13:20

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23